Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 6/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
SYNT Stock Overview
SyntheticMR AB (publ) develops and markets software solutions for magnetic resonance imaging (MRI) in Sweden and internationally.
SyntheticMR AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr38.00 |
52 Week High | kr79.40 |
52 Week Low | kr22.40 |
Beta | 1.04 |
1 Month Change | 22.58% |
3 Month Change | 31.94% |
1 Year Change | -8.65% |
3 Year Change | 40.22% |
5 Year Change | 29.25% |
Change since IPO | 1,420.00% |
Recent News & Updates
What Does SyntheticMR AB (publ)'s (NGM:SYNT) Share Price Indicate?
While SyntheticMR AB (publ) ( NGM:SYNT ) might not be the most widely known stock at the moment, it saw a significant...
Shareholder Returns
SYNT | SE Healthcare Services | SE Market | |
---|---|---|---|
7D | -3.8% | -0.9% | 3.5% |
1Y | -8.7% | 1.5% | -20.7% |
Return vs Industry: SYNT underperformed the Swedish Healthcare Services industry which returned 3.9% over the past year.
Return vs Market: SYNT exceeded the Swedish Market which returned -20.9% over the past year.
Price Volatility
SYNT volatility | |
---|---|
SYNT Average Weekly Movement | 10.2% |
Healthcare Services Industry Average Movement | 7.6% |
Market Average Movement | 7.1% |
10% most volatile stocks in SE Market | 12.5% |
10% least volatile stocks in SE Market | 4.5% |
Stable Share Price: SYNT is more volatile than 75% of Swedish stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: SYNT's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2007 | 27 | Ulrik Harrysson | https://www.syntheticmr.com |
SyntheticMR AB (publ) develops and markets software solutions for magnetic resonance imaging (MRI) in Sweden and internationally. The company’s SyMRI delivers various contrast images, biomarker segmentations, and quantitative data with a single MR sequence. It also offers SyMRI NEURO that delivers multiple contrast images, tissue segmentations, and quantitative data on the brain, as well as objective decision support; SyMRI MSK which provides multiple contrast images and quantitative data for MSK anatomies; and MAGiC, a customized version of SyMRI.
SyntheticMR AB (publ) Fundamentals Summary
SYNT fundamental statistics | |
---|---|
Market Cap | kr1.63b |
Earnings (TTM) | kr1.75m |
Revenue (TTM) | kr58.24m |
907.1x
P/E Ratio27.2x
P/S RatioIs SYNT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SYNT income statement (TTM) | |
---|---|
Revenue | kr58.24m |
Cost of Revenue | kr20.35m |
Gross Profit | kr37.88m |
Other Expenses | kr36.14m |
Earnings | kr1.75m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
Aug 23, 2022
Earnings per share (EPS) | 0.042 |
Gross Margin | 65.05% |
Net Profit Margin | 3.00% |
Debt/Equity Ratio | 0% |
How did SYNT perform over the long term?
See historical performance and comparison